The Ca2+ binding properties of the FHC-associated cardiac troponin C (cTnC) mutation L29Q were examined in isolated cTnC, troponin complexes, reconstituted thin filament preparations, and skinned cardiomyocytes. While higher Ca2+ binding affinity was apparent for the L29Q mutant in isolated cTnC, this phenomenon was not observed in the cTn complex. At the level of the thin filament in the presence of phosphomimetic TnI, L29Q cTnC further reduced the Ca2+ affinity by 27% in the steady-state measurement and increased the Ca2+ dissociation rate by 20% in the kinetic studies. Molecular dynamics simulations suggest that L29Q destabilizes the conformation of cNTnC in the presence of phosphomimetic cTnI and potentially modulates the Ca2+ sensitivi...
Hypertrophic Cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young adults under...
Cardiac diseases associated with mutations in Tn subunits include hypertrophic cardiomyopathy (HCM),...
Previous studies of cardiomyopathy-related mutations in cardiac troponin C (cTnC)—L29Q and G159D—hav...
The Ca2+ binding properties of the FHC-associated cardiac troponin C (cTnC) mutation L29Q were exami...
AbstractFamilial hypertrophic cardiomyopathy (FHC) is characterized by severe abnormal cardiac muscl...
Troponin I mutations have been linked to genetic hypertrophic and dilated cardiomyopathies. We aimed...
Cardiac troponin C (cTnC) is a highly conserved Ca2+ binding protein that plays an essential role in...
Troponin I mutations have been linked to genetic hypertrophic and dilated cardiomyopathies. We aimed...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease that could res...
AbstractFamilial hypertrophic cardiomyopathy (FHC) is characterized by severe abnormal cardiac muscl...
Human cardiac troponin C (HcTnC), the regulatory calcium-binding component of the troponin complex, ...
The cardiac troponin I (cTnI) R145W mutation is associated with restrictive cardiomyopathy (RCM). Re...
Cardiac troponin I (cTnI) is the inhibitory component of the troponin complex and is involved in the...
Troponin C (TnC) is implicated in the initiation of myocyte contraction via binding of cytosolic Ca2...
Three novel mutations (G159D, L29Q and E59D/D75Y) in cardiac troponin C (CTnC) associate their clini...
Hypertrophic Cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young adults under...
Cardiac diseases associated with mutations in Tn subunits include hypertrophic cardiomyopathy (HCM),...
Previous studies of cardiomyopathy-related mutations in cardiac troponin C (cTnC)—L29Q and G159D—hav...
The Ca2+ binding properties of the FHC-associated cardiac troponin C (cTnC) mutation L29Q were exami...
AbstractFamilial hypertrophic cardiomyopathy (FHC) is characterized by severe abnormal cardiac muscl...
Troponin I mutations have been linked to genetic hypertrophic and dilated cardiomyopathies. We aimed...
Cardiac troponin C (cTnC) is a highly conserved Ca2+ binding protein that plays an essential role in...
Troponin I mutations have been linked to genetic hypertrophic and dilated cardiomyopathies. We aimed...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease that could res...
AbstractFamilial hypertrophic cardiomyopathy (FHC) is characterized by severe abnormal cardiac muscl...
Human cardiac troponin C (HcTnC), the regulatory calcium-binding component of the troponin complex, ...
The cardiac troponin I (cTnI) R145W mutation is associated with restrictive cardiomyopathy (RCM). Re...
Cardiac troponin I (cTnI) is the inhibitory component of the troponin complex and is involved in the...
Troponin C (TnC) is implicated in the initiation of myocyte contraction via binding of cytosolic Ca2...
Three novel mutations (G159D, L29Q and E59D/D75Y) in cardiac troponin C (CTnC) associate their clini...
Hypertrophic Cardiomyopathy (HCM) is the leading cause of sudden cardiac death in young adults under...
Cardiac diseases associated with mutations in Tn subunits include hypertrophic cardiomyopathy (HCM),...
Previous studies of cardiomyopathy-related mutations in cardiac troponin C (cTnC)—L29Q and G159D—hav...